Home › Steatotic Liver Disease › California › Santa Maria
Steatotic Liver Disease clinical trials in Santa Maria, CA
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Santa Maria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Santa Maria
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Santa Maria
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RecruitingPhase 2
- GSK Investigational Site, Santa Maria
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
- Orlando, FL9 studies
Other studies in Santa Maria
- Prostate Cancer7 studies
- Breast Cancer5 studies
- Heart Failure4 studies
- Rectal Cancer4 studies
- Colon Cancer4 studies
- Colorectal Cancer4 studies
- Non-Small Cell Lung Cancer3 studies
- Lung Cancer3 studies
- Bladder Cancer3 studies
- Stomach Cancer3 studies
- Melanoma3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.